ROBINSON JAMES GEORGE purchased 0.3% of their position (10K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $15.9K — a small addition. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 6/4/2019ACC: 0001651844-19-000005
Director
Since Oct 2018
+10K
Net shares
Net buyer
$15.9K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
10K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.00
Price / share
$1.58
Trade value
$11.06
% of position
0.0%
5/31/2019
3.34M→3.34M
Common Stock
Direct
Shares
+8.60K
Price / share
$1.59
Trade value
$13.67K
% of position
0.3%
5/31/2019
3.34M→3.35M
Common Stock
Direct
Shares
+300.00
Price / share
$1.60
Trade value
$480.00
% of position
0.0%
5/31/2019
3.35M→3.35M
Common Stock
Direct
Shares
+1.09K
Price / share
$1.61
Trade value
$1.76K
% of position
0.0%
5/31/2019
3.35M→3.35M
Total
Net shares
+10K
Net value
$15.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2019 | P · Purchase | +7.00 | $1.58 | $11.06 | 0.0% | 3.34M | 3.34M |
| Common Stock Direct | 5/31/2019 | P · Purchase | +8.60K | $1.59 | $13.67K | 0.3% | 3.34M | 3.35M |
| Common Stock Direct | 5/31/2019 | P · Purchase | +300.00 | $1.60 | $480.00 | 0.0% | 3.35M | 3.35M |
| Common Stock Direct | 5/31/2019 | P · Purchase | +1.09K | $1.61 | $1.76K | 0.0% | 3.35M | 3.35M |
| Total | +10K | $15.92K | ||||||
Derivative Transactions0
No derivative transactions reported